Gemeinschaftspraxis Nittendorf

The research at Gemeinschaftspraxis Nittendorf includes trials aimed at preventing heart failure and lowering the risk of cardiovascular death.

• Evaluating combination therapy with dapagliflozin to reduce heart failure events
• Assessing novel agents for early intervention in high‑risk patients
• Exploring strategies to improve long‑term cardiovascular outcomes

These studies seek to provide safer and more effective options for individuals vulnerable to heart failure, ultimately improving survival and quality of life.

Clinical investigations focus on advancing care for adults with type 2 diabetes mellitus.

• Testing the added benefit of new agents on glycemic control
• Comparing combination therapy versus standard treatment alone
• Monitoring safety and effectiveness of adjunctive diabetes medications

The purpose is to identify more efficient treatment regimens that better manage blood sugar levels and reduce complications associated with diabetes.